Engineered Enucleated Mesenchymal Stem Cells Regulating Immune Microenvironment and Promoting Wound Healing
Zhengtai Chen1, Yang Zou1,2, Hanxiao Sun1
1Department of Plastic Surgery, The Second Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, 310000, China.
Advanced Materials (Deerfield Beach, Fla.)
|September 19, 2024
Summary
Engineered enucleated mesenchymal stem cells, termed Cargocytes, effectively target and reduce inflammation in wound healing. This novel approach sustains interleukin-4 expression, improving macrophage function and promoting better wound repair.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Immunology
Background:
- Persistent inflammation from immune cell dysfunction hinders wound healing.
- Existing cytokine therapies have limitations like short half-lives and poor targeting.
Purpose of the Study:
- To develop a novel drug delivery vector for enhanced wound healing.
- To engineer enucleated mesenchymal stem cells for targeted and sustained therapeutic delivery.
Main Methods:
- Engineered enucleated mesenchymal stem cells (Cargocytes) using aptamer bioorthogonal chemistry.
- Modified cell membranes for targeting and loaded mRNA for sustained cytokine secretion.
- Targeted neutrophils' NETosis via DEK protein and sustained interleukin-4 (IL-4) expression.
Main Results:
- Cargocytes effectively reduced NETosis and prevented M1 macrophage polarization.
- Sustained IL-4 expression was achieved, overcoming limitations of free IL-4.
- Therapeutic effects were validated in murine and porcine wound models.
Conclusions:
- Engineered enucleated mesenchymal stem cells (Cargocytes) show promise as a wound healing therapy.
- This approach effectively modulates the wound immune microenvironment.
- Cargocytes offer a potential strategy for refractory wound treatment.
Related Concept Videos
Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K


